Congresses & Publications

Advanced NanoBiomed Research

July 12, 2026: hemotune AG publishes GLP-compliant preclinical safety data for the HemoSystem, supporting initiation of clinical trials

Mora, et al., Safety and Feasibility of Magnetic Separation-Based Blood Purification. Advanced NanoBiomed Research 2026, 6 (10), e70141.

The full publication is available open access: Safety and Feasibility of Magnetic Separation-Based Blood Purification

Sepsis Update – Heidelberg, Germany, 2025

Extracorporeal Blood Purification System Using Magnetic Particles in Septic Shock Therapy: Development and Preclinical Evaluation

Jan Waskowski1, Jean-Claude Metzger2, Manuel Baumgartner2, Carlos Mora2, Eva-Maria Kleinert3, Sascha David3, Joerg C. Schefold1

1 Inselspital, Universitätsspital Bern, Universitätsklinik für Intensivmedizin, Freiburgstrasse, 3010 Bern, Switzerland

2 hemotune AG, Wagistrasse 27, 8952 Schlieren, Switzerland

3 Universitätsspital Zürich, Institut für Intensivmedizin, Rämistrasse 100, 8091 Zürich, Switzerland

congress: ESGcT 2025, Sevilla, Spain

The extracorporeal HemoSystem DEPLETE effectively and selectively removes anti-AAV antibodies

Giulia Mearini, Laurine Rijsbergen, Manuel Baumgartner, Nadia Cereghetti, Tanja Sigg, Mathishan Maheswaran, Priscilla Mullin, Sebastian Benz, Jean-Claude Metzger, Lukas Langenegger, Carlos Mora

hemotune AG, Schlieren, 8952, Switzerland

Congress: ESGcT 2024, Rome, Italy

Overcoming pre-existing immunity in gene therapy: the HemoSystem DEPLETE approach

 

Carlos Mora, Laurine Rijsbergen, Sarah Keller, Nadia Cereghetti, Lukas Langenegger

hemotune AG, Schlieren, 8952, Switzerland

Visit Study